Current Report Filing (8-k)
04 11월 2016 - 5:15AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
Date of report (Date of earliest event reported): November 2, 2016
ZOSANO PHARMA CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-36570
|
|
45-4488360
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
34790 Ardentech Court
Fremont, CA 94555
(Address of principal executive offices) (Zip Code)
(510) 745-1200
Registrants telephone number, including area code
Not applicable
(Former
name or former address, if changed since last report.)
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.07.
|
Submission of Matters to a Vote of Security Holders
|
On November 2, 2016, we held
our annual meeting of stockholders. A total of 16,815,997 shares of our common stock were outstanding as of October 6, 2016, the record date for the annual meeting. Set forth below are the matters acted upon at the annual meeting and the final
voting results on each matter as reported by our inspector of elections.
Proposal One: Election of Directors
Our stockholders elected Bruce D. Steel as a member of our board of directors as a Class II director for a three-year term. The results of
the vote were as follows:
|
|
|
|
|
|
|
Nominee
|
|
For
|
|
Withheld
|
|
Broker
Non-Votes
|
Bruce D. Steel
|
|
9,419,752
|
|
278,986
|
|
1,782,566
|
Proposal Two: Ratification of Marcum LLP as our Independent Registered Public Accountants for Fiscal 2016
Our stockholders ratified our selection of Marcum LLP as our independent registered public accountants for our fiscal year ending
December 31, 2016. The results of the vote were as follows:
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
|
Broker
Non-Votes
|
10,650,593
|
|
9,714
|
|
820,997
|
|
0
|
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
ZOSANO PHARMA
CORPORATION
|
|
|
|
|
Dated: November 3, 2016
|
|
|
|
By:
|
|
/s/ Georgia Erbez
|
|
|
|
|
|
|
Name: Georgia Erbez
|
|
|
|
|
|
|
Title: Chief Business Officer and Interim Chief Financial Officer
|
3
Zosano Pharma (NASDAQ:ZSAN)
과거 데이터 주식 차트
부터 9월(9) 2024 으로 10월(10) 2024
Zosano Pharma (NASDAQ:ZSAN)
과거 데이터 주식 차트
부터 10월(10) 2023 으로 10월(10) 2024
Zosano Pharma Corporation (나스닥)의 실시간 뉴스: 최근 기사 0
More Zosano Pharma Corp News Articles